Skip to content

The safety and efficacy of Yu-Qi-Dai (Yu-Qi Tai-Du-Qing) for the prevention of neonatal jaundice

The safety and efficacy of Yu-Qi-Dai (Yu-Qi Tai-Du-Qing) for the prevention of neonatal jaundice: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028056
Enrollment
Unknown
Registered
2019-12-09
Start date
2020-02-12
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal jaundice

Interventions

Sponsors

Jiangxi TongTianLe Technology Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Neonates born within 0 to 1 day; (2) Birth weight: 2500 to 4000g; (3) Apgar score: 7 to 10 points; (4) By vaginal delivery or caesarean delivery, gestational age: 37 to 42 weeks; (5) The age of the mother is 23 to 35 years old; (6) The mother has no pregnancy, childbirth complications and complications.

Exclusion criteria

Exclusion criteria: (1) Newborns with birth injury; (2) Newborns with malformation or other disease; (3) Severe neonatal hemolytic; (4) Either of the parents has a history of allergies.

Design outcomes

Primary

MeasureTime frame
Effective rate;

Secondary

MeasureTime frame
Transcutaneous bilirubin;Timing of passage of first meconium;Timing of meconium turned yellow;Timing of onset of jaundice ;Timing of jaundice subsided;Status of falling-off of umbilical cord;

Countries

China

Contacts

Public ContactWang Xin

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

wx1501@aliyun.com+86 18801062391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026